Source:http://linkedlifedata.com/resource/pubmed/id/11165226
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2001-2-22
|
pubmed:abstractText |
We compared the effects of carvedilol on atrial-His and His-ventricular conduction with those of propranolol in isolated rat hearts. Hearts were perfused retrograde, and atrial-His and His-ventricular intervals were measured. The effective doses that increased conduction times by 25% were 10(-6) M for atrial-His and 3x10(-6) M for His-ventricular for propranolol, and 8x10(-8) M for atrial-His and 10(-8) M for His-ventricular for carvedilol. Prazosin did not affect the atrial-His and His-ventricular intervals. After ischemia-reperfusion, atrial-His and His-ventricular intervals increased to a greater extent with 10(-6) M carvedilol. To determine the direct membrane effect, we examined the transmembrane action potential in guinea pig papillary muscle. Both drugs decreased the maximum upstroke velocity equally. Our data indicate that carvedilol had a greater effect on atrioventricular conduction in the setting of ischemia-reperfusion than did propranolol. This effect of carvedilol was not due to its alpha-adrenoceptor blocking property or to a direct membrane effect.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Carbazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Prazosin,
http://linkedlifedata.com/resource/pubmed/chemical/Propanolamines,
http://linkedlifedata.com/resource/pubmed/chemical/Propranolol,
http://linkedlifedata.com/resource/pubmed/chemical/carvedilol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
412
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
145-53
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11165226-Action Potentials,
pubmed-meshheading:11165226-Adrenergic alpha-Antagonists,
pubmed-meshheading:11165226-Adrenergic beta-Antagonists,
pubmed-meshheading:11165226-Animals,
pubmed-meshheading:11165226-Bundle of His,
pubmed-meshheading:11165226-Carbazoles,
pubmed-meshheading:11165226-Guinea Pigs,
pubmed-meshheading:11165226-Male,
pubmed-meshheading:11165226-Myocardial Ischemia,
pubmed-meshheading:11165226-Papillary Muscles,
pubmed-meshheading:11165226-Prazosin,
pubmed-meshheading:11165226-Propanolamines,
pubmed-meshheading:11165226-Propranolol,
pubmed-meshheading:11165226-Rats,
pubmed-meshheading:11165226-Rats, Sprague-Dawley,
pubmed-meshheading:11165226-Reperfusion Injury
|
pubmed:year |
2001
|
pubmed:articleTitle |
Effect of carvedilol on atrioventricular conduction in the ischemic heart.
|
pubmed:affiliation |
The First Department of Internal Medicine, Nagoya City University Medical School, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Aichi-ken, Nagoya, Japan. horioto@rcs.tokai.west.ntt.co.jp
|
pubmed:publicationType |
Journal Article
|